(self.webpackChunk_N_E=self.webpackChunk_N_E||[]).push([[931],{1229:function(e,a,t){Promise.resolve().then(t.bind(t,5438))},5438:function(e,a,t){"use strict";t.r(a),t.d(a,{default:function(){return h}});var i=t(7437),n=t(2265),s=t(7042),l=t(4769);let r=n.forwardRef((e,a)=>{let{className:t,...n}=e;return(0,i.jsx)("div",{ref:a,className:function(){for(var e=arguments.length,a=Array(e),t=0;t<e;t++)a[t]=arguments[t];return(0,l.m6)((0,s.W)(a))}("rounded-xl border border-gray-200 bg-white text-gray-950 shadow dark:border-gray-800 dark:bg-gray-800 dark:text-gray-50",t),...n})});r.displayName="Card";var o=t(8203),c=t(1298),d=t(8783),m=t(1291),u=t(7158);let x=e=>{let{drug:a}=e,t=e=>e>=90?"bg-green-600":e>=70?"bg-yellow-500":"bg-red-500";return(0,i.jsxs)(r,{className:"relative min-w-[400px] overflow-hidden transform transition-all duration-300 hover:scale-105 hover:shadow-2xl bg-white rounded-xl border border-gray-200",children:[(0,i.jsx)("div",{className:"bg-gradient-to-r from-indigo-600 to-blue-700 p-6 text-white",children:(0,i.jsxs)("div",{className:"space-y-2",children:[(0,i.jsx)("h3",{className:"text-3xl font-bold tracking-tight",children:a.name}),(0,i.jsx)("p",{className:"text-base text-indigo-100 font-medium",children:a.company})]})}),(0,i.jsxs)("div",{className:"p-6 space-y-6 bg-gradient-to-b from-white to-gray-50",children:[(0,i.jsxs)("div",{className:"grid grid-cols-2 gap-6",children:[(0,i.jsxs)("div",{children:[(0,i.jsxs)("div",{className:"flex items-center text-gray-700 mb-2",children:[(0,i.jsx)(o.Z,{className:"w-5 h-5 mr-2 text-indigo-600"}),(0,i.jsx)("span",{className:"text-sm font-semibold",children:"Expected Launch"})]}),(0,i.jsx)("p",{className:"font-bold text-lg text-gray-900 ml-7",children:a.launch})]}),(0,i.jsxs)("div",{children:[(0,i.jsxs)("div",{className:"flex items-center text-gray-700 mb-2",children:[(0,i.jsx)(c.Z,{className:"w-5 h-5 mr-2 text-indigo-600"}),(0,i.jsx)("span",{className:"text-sm font-semibold",children:"2030 Sales"})]}),(0,i.jsxs)("p",{className:"font-bold text-lg text-gray-900 ml-7",children:["$",a.sales,"B"]})]})]}),(0,i.jsxs)("div",{className:"space-y-6",children:[(0,i.jsxs)("div",{children:[(0,i.jsx)("h4",{className:"font-bold text-lg text-gray-900 mb-2",children:"Indication"}),(0,i.jsx)("p",{className:"text-base text-gray-700 leading-relaxed",children:a.indication})]}),(0,i.jsxs)("div",{children:[(0,i.jsx)("h4",{className:"font-bold text-lg text-gray-900 mb-2",children:"Mechanism of Action"}),(0,i.jsx)("p",{className:"text-base text-gray-700 leading-relaxed",children:a.moa})]})]}),(0,i.jsxs)("div",{className:"space-y-4",children:[(0,i.jsx)("h4",{className:"font-bold text-lg text-gray-900",children:"Success Probability"}),a.probabilities.map((e,a)=>(0,i.jsxs)("div",{className:"space-y-2",children:[(0,i.jsxs)("div",{className:"flex justify-between items-center",children:[(0,i.jsx)("span",{className:"text-base text-gray-700 font-medium",children:e.context}),(0,i.jsxs)("span",{className:"font-bold text-gray-900",children:[e.value,"%"]})]}),(0,i.jsx)("div",{className:"h-3 bg-gray-100 rounded-full overflow-hidden",children:(0,i.jsx)("div",{className:"h-full rounded-full transition-all duration-500 ".concat(t(e.value)),style:{width:"".concat(e.value,"%")}})})]},a))]}),(0,i.jsxs)("div",{className:"space-y-4",children:[(0,i.jsx)("h4",{className:"font-bold text-lg text-gray-900",children:"Key Features"}),(0,i.jsx)("ul",{className:"space-y-3",children:a.features.map((e,a)=>(0,i.jsxs)("li",{className:"flex items-start group",children:[(0,i.jsx)(d.Z,{className:"w-5 h-5 mr-2 mt-0.5 text-indigo-600 transform group-hover:translate-x-1 transition-transform"}),(0,i.jsx)("span",{className:"text-base text-gray-700",children:e})]},a))})]})]})]})};var h=()=>{let e=(0,n.useRef)(null),[a,t]=(0,n.useState)("All"),s=a=>{let t=e.current;if(!t)return;let i=t.scrollLeft+("left"===a?-450:450);t.scrollTo({left:i,behavior:"smooth"})},l=[{name:"AWIQLI",company:"Novo Nordisk",launch:"2024-2025",sales:4.7,indication:"Type 1 and Type 2 Diabetes Mellitus",moa:"Long-acting basal insulin analog",probabilities:[{value:95,context:"United States"}],features:["First once-weekly insulin","Mobile app for dose optimization","Similar hypoglycemia rates to daily insulin"]},{name:"CagriSema",company:"Novo Nordisk",launch:"2026-2027",sales:8.3,indication:"Obesity and Type 2 Diabetes",moa:"GLP-1 RA + long-acting amylin analog",probabilities:[{value:71,context:"European Union"}],features:["First FDC amylin and GLP-1 RA","Superior weight loss vs. existing options","Potential cardiovascular benefits"]},{name:"COBENFY",company:"Bristol Myers Squibb",launch:"2024",sales:1.6,indication:"Schizophrenia",moa:"Dual M1/M4 muscarinic receptor agonist",probabilities:[{value:21,context:"European Union"}],features:["First novel MOA in 30+ years","Improved tolerability profile","Potential for earlier line use"]},{name:"EBGLYSS",company:"Eli Lilly & Co",launch:"2024",sales:6,indication:"Atopic Dermatitis",moa:"IL-13-targeting monoclonal antibody",probabilities:[{value:56,context:"Mainland China"}],features:["Less frequent dosing than competitors","Strong efficacy profile","Favorable safety data"]},{name:"Fitusiran",company:"Alnylam/Sanofi",launch:"2025",sales:1,indication:"Hemophilia A and B",moa:"Antithrombin-targeting siRNA",probabilities:[{value:95,context:"United States"}],features:["Monthly/bimonthly dosing","Effective regardless of inhibitor status","Reduced treatment burden"]},{name:"GSK-3536819",company:"GSK",launch:"2025",sales:.91,indication:"Meningococcal Disease",moa:"Pentavalent vaccine targeting N. meningitidis",probabilities:[{value:90,context:"European Union"}],features:["5-in-1 vaccine targeting major strains","Reduced number of injections","Potential for broader population coverage"]},{name:"IMDELLTRA",company:"Amgen",launch:"2024",sales:2.1,indication:"Small-cell Lung Cancer",moa:"DLL3 \xd7 CD3-targeting BiTE molecule",probabilities:[{value:79,context:"European Union"}],features:["First-in-class DLL3 \xd7 CD3 BiTE","Impressive efficacy in SCLC","Potential for multiple indications"]},{name:"mRESVIA",company:"Moderna",launch:"2024",sales:1.4,indication:"RSV",moa:"mRNA vaccine",probabilities:[{value:90,context:"Japan"}],features:["First mRNA-based RSV vaccine","Single-dose administration","Strong efficacy profile"]},{name:"SEL-212",company:"Sobi",launch:"2025",sales:1.7,indication:"Gout",moa:"ImmTOR + pegylated uricase",probabilities:[{value:95,context:"United States"}],features:["Novel immune tolerance technology","Monthly administration","Improved immunogenicity profile"]},{name:"Vepdegestrant",company:"Arvinas/Pfizer",launch:"2025",sales:1.19,indication:"Breast Cancer",moa:"ER PROTAC degrader",probabilities:[{value:64,context:"European Union"}],features:["First PROTAC protein degrader","Novel approach to ER degradation","Potential for combination therapy"]},{name:"Zanzalintinib",company:"Exelixis",launch:"2026",sales:2.6,indication:"Multiple Cancers",moa:"Multi-targeted tyrosine kinase inhibitor",probabilities:[{value:43,context:"United States"}],features:["Third-generation TKI","Multiple cancer indications","Improved pharmacokinetics"]}].filter(e=>"All"===a||e.probabilities.some(e=>e.context===a));return(0,i.jsx)("div",{className:"min-h-screen bg-gradient-to-br from-indigo-50 via-white to-blue-50 p-8",children:(0,i.jsxs)("div",{className:"max-w-[95%] mx-auto space-y-12",children:[(0,i.jsxs)("div",{className:"text-center space-y-2",children:[(0,i.jsx)("h1",{className:"text-5xl font-bold bg-gradient-to-r from-indigo-600 to-blue-700 bg-clip-text text-transparent leading-tight pb-2",children:"2025 Drugs to Watch"}),(0,i.jsx)("p",{className:"text-xl text-gray-600 font-medium",children:"Comprehensive Analysis & Market Outlook"})]}),(0,i.jsx)("div",{className:"flex justify-center gap-4 mb-8",children:["All","United States","European Union","Japan","Mainland China"].map(e=>(0,i.jsx)("button",{onClick:()=>t(e),className:"px-4 py-2 rounded-full transition-all duration-200 ".concat(a===e?"bg-indigo-600 text-white shadow-lg":"bg-white text-gray-600 hover:bg-gray-50"),children:e},e))}),(0,i.jsxs)("div",{className:"relative",children:[(0,i.jsx)("button",{onClick:()=>s("left"),className:"absolute left-0 top-1/2 -translate-y-1/2 -translate-x-4 z-10 p-3 rounded-full bg-white shadow-lg hover:bg-gray-50 transition-all duration-200 hover:scale-110 focus:outline-none group",children:(0,i.jsx)(m.Z,{className:"w-6 h-6 text-gray-600 group-hover:text-indigo-600"})}),(0,i.jsx)("div",{ref:e,className:"flex overflow-x-auto gap-8 py-8 px-8 hide-scrollbar snap-x snap-mandatory",style:{scrollbarWidth:"none",msOverflowStyle:"none"},children:l.map((e,a)=>(0,i.jsx)("div",{className:"snap-center flex-shrink-0",children:(0,i.jsx)(x,{drug:e})},a))}),(0,i.jsx)("button",{onClick:()=>s("right"),className:"absolute right-0 top-1/2 -translate-y-1/2 translate-x-4 z-10 p-3 rounded-full bg-white shadow-lg hover:bg-gray-50 transition-all duration-200 hover:scale-110 focus:outline-none group",children:(0,i.jsx)(u.Z,{className:"w-6 h-6 text-gray-600 group-hover:text-indigo-600"})})]})]})})}}},function(e){e.O(0,[287,971,938,744],function(){return e(e.s=1229)}),_N_E=e.O()}]);